Prof. Christopher Brightling
National Institute for Health Research Senior Investigator
Christopher Brightling is a National Institute for Health Research Senior Investigator, former Wellcome Trust Senior Clinical Fellow, Honorary Consultant Respiratory Physician at the Institute for Lung Health, Leicester, UK.
He is Clinical Interventions Theme Lead for the Leicester NIHR Respiratory Biomedical Unit and a Coordinator for the European Union Consortium AirPROM, MRC/ABPI COPD (COPDMAP) Consortium and the MRC Molecular Pathology Node EMBER. As a well-respected expert in the immunopathogenesis of airway diseases, particularly asthma, chronic cough and COPD, his current projects include understanding the interactions between mast cells and airway smooth muscle cells in the development of the asthmatic phenotype, and migration and remodeling of airway smooth muscle in asthma and COPD.
Professor Brightling has published over 275 peer-reviewed articles and has an h-index of 70 (google scholar). He has been an invited speaker at over 20 international meetings within the last 5 years. Professor Brightling is Associate Editor of the prestigious CHEST and Clinical Science journals and has contributed to updates for the American College of Chest Physicians’ Cough Guidelines, the British Thoracic Society Difficult Asthma Guidelines, the World Health Organization Severe Asthma Strategy and the American Thoracic Society/European Respiratory Society Severe Asthma Task Force.